Evaluation of contemporary olanzapine- and netupitant/palonosetron-containing antiemetic regimens for chemotherapy-induced nausea and vomiting

CONCLUSION: These results do not conclusively support the superiority of either regimen for patients with breast cancer who are receiving AC.PMID:36810240 | DOI:10.12809/hkmj209182

Source: Hong Kong Medical Journal - February 22, 2023 Category: General Medicine Authors: C Ch Yip L Li T K H Lau V T C Chan C C H Kwok J J S Suen F K F Mo W Yeo Source Type: research